Avectas Ltd.. (4/9/19). "Press Release: Avectas Raises $10 Million in Equity Finance". Ireland.

	Organisation	Avectas Ltd.
	Organisation 2	Maynooth University
	Product	Solupore® cell engineering technology platform
	Product 2	venture capital
	Index term	Avectas–SEVERAL: investment, 201904 financing round $10m led by Seamus Mulligan
	Person	Mulligan, Seamus (Azur Pharma 200702 CEO + Chairman)
	Person 2	Maguire, Michael (Avectas 202004 CEO)

Investment Will Be Used To Advance the Development of Solupore®, its non-viral cell engineering technology

Cell engineering technology business Avectas has completed a US$10 million equity financing with a group of experienced biotechnology investors. The investment round was led by leading pharmaceutical sector investor Seamus Mulligan. Avectas collaborates with leading cell and gene therapy businesses and academic institutions to address their cell engineering challenges using its patented Solupore® technology.

“The Avectas team is delighted to receive this significant endorsement from a highly experienced group of investors,” said Dr. Michael Maguire, co-founder and CEO of Avectas. “This funding, which builds on our recent Horizon 2020 award, provides us with the financial resources to accelerate the development, scale-up and commercialisation of Solupore®.”

Cell and gene therapies offer the potential to transform the treatment of diseases, including cancer, for millions of patients worldwide. However new engineering technologies are required to enable these cutting-edge therapies to achieve their potential. Avectas is developing a patented, non-viral, cell engineering technology which efficiently engineers therapeutic cells, at scale, while maintaining optimal cell functionality.

About Avectas

Founded in 2012 as a spin-out from Maynooth University in Ireland by Dr. Michael Maguire and Dr. Shirley O’Dea, Avectas has 24 employees including 13 with doctorate degrees. ?

Record changed: 2023-06-05

Picture Berlin Partner Voices Robinson Data for Precision Medicine 650x200px

More documents for Avectas Ltd.

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)